The first generics of Gilenya have been approved by the FDA
The first three applications for generics of Gilenya (fingolimod) capsules for the treatment of relapsing forms of MS have been approved.
List view / Grid view
The first three applications for generics of Gilenya (fingolimod) capsules for the treatment of relapsing forms of MS have been approved.
The FDA has approved Gilenya to treat relapsing multiple sclerosis in children and adolescents age 10 years and older...